Giant negative T waves in Guillain-Barre syndrome

Acta Neurologica Scandinavica

Volumn 101, Issue 3, 2000, Pages 212-215

  Yoshii, Fumihito ^a   Kozuma, R ^a   Haida, M ^a   Shinohara, Y ^a   Yoshitake, M ^a   Abe, S ^a   Handa, S ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

123I MIBG myocardial scintigraphy; Electrocardiography; Giant negative T waves; Guillain Barre syndrome

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; DOPAMINE; IMMUNOGLOBULIN; NORADRENALIN; TETROFOSMIN TC 99M;

AGED; ARTICLE; CASE REPORT; ELECTROCARDIOGRAPHY; FEMALE; GUILLAIN BARRE SYNDROME; HEART LEFT VENTRICLE WALL MOTION; HEART MUSCLE INJURY; HEART NERVE; HEART SCINTISCANNING; HUMAN; HYPOKINESIA; NORADRENALIN BLOOD LEVEL; SYMPATHETIC NERVE; T WAVE; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

3-IODOBENZYLGUANIDINE; AGED; ECHOCARDIOGRAPHY; FEMALE; GUILLAIN-BARRE SYNDROME; HEART; HUMANS; MEDIAN NERVE; NEURAL CONDUCTION; PERONEAL NERVE; SEVERITY OF ILLNESS INDEX; SYMPATHOLYTICS; SYSTOLE; TIBIAL NERVE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0033998291     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0404.2000.101003212.x     Document Type: Article

References (15)

1. 1. Palferman TG, Wright I, Doyle DV, Amiel S. Electrocardiographic abnormalities and autonomic dysfunction in Guillain Barré syndrome. Brit Med J 1982;284:1231-2.
2. 2. Iga K, Himura Y, Izumi C et al. Reversible left ventricular dysfunction associated with Guillain-Barré syndrome. An expression of catecholamine cardiotoxicity? Jpn Circ J 1995;59:236-40.
3. 3. Yanowitz F, Preston JB, Abildskov JA. Functional distribution of right and left stellate innervation to the ventricles: Production of neurogenic electrocardiographic changes by unilateral alteration of sympathetic tone. Circ Res 1966:18:416-28.
4. 4. Murayama M, Mashima S, Shimomura K, Takayanagi K, Tseng YZ, Murao S. An experimental model of giant negative T wave associated with QT prolongation produced by combined effect of calcium and isoproterenol. Jpn Heart J 1981;22:257-65.
5. 5. Wieland DM, Brown LE, Rogers WL et al. Myocardial imaging with a radioiodinated norepinephrine storage analog. J Nucl Med 1981;22:22-31.
6. 123I] iodobenzylguanidine in neurological patients with autonomic failure. J Auton Nerv Syst 1994;49:81-4.
7. 7. Yoshita M. Differentiation of idiopathic Parkinson's disease from striatonigral degeneration and progressive supranuclear palsy using iodine-123 meta-iodobenzylguanidine myocardial scintigraphy. J Neurol Sci 1998;155: 60-7.
8. 123I] metaiodobenzylguanidine. Diabetes 1992;41:1069-75.
9. 9. Machida K, Honda N, Mamiya T et al. Abnormal sympathetic innervation of the heart in a patient with myotonic dystrophy detected with I-123 MIBG cardiac SPECT. Clin Nucl Med 1994;19:968-72.
10. 10. Macfarlane PW, Veitch Lawrie TD eds. Comprehensive electrocardiography. Theory and practice in health and disease. New York: Pergamon Press, 1989;709-15.
11. 11. Sission JC, Shapiro B, Meyers L et al. Metaiodobenzylguanidine to map scintigraphically the adrenergic nervous system in man. J Nucl Med 1987;28:1625-36.
12. 12. Maier H, Schmidbauer M, Pfausler B, Schmutzhard E, Budka H. Central nervous system pathology in patients with the Guillain Barré syndrome. Brain 1997;120:451-64.
13. 13. Benarroch EE. The central autonomic network: Functional organization, dysfunction, and perspective. Mayo Clin Proc 1993;68:988-1001.
14. 14. Rona G. Catecholamine cardiotoxicity. J Mol Cell Cardiol 1985;17:291-306.
15. 15. Yamanaka O, Fujiwara Y, Nakamura T et al. "Myocardial stunning"-like phenomenon during a crisis of pheochromocytome. Jpn Circ J 1994;58:737-42.